$UCBJY News Article - ZILBRYSQ (zilucoplan) Is Now Commercially Available in the U.S. for the Treatment of Generalized Myasthenia Gravis (gMG) in Adult Patients Who Are Anti-Acetylcholine Receptor (AChR) Antibody Positive https://marketwirenews.com/news-releases/zilb...38743.html